Tilray Q1 2027 Earnings: Record Revenue, Global Diversification Strategy Accelerating

Tilray Brands (TLRY) Q1 2027 Earnings Report: Diversification Drives Global Growth

[Date: October 8, 2026]

[Introduction]

Tilray Brands, Inc. (NASDAQ: TLRY) reported its first-quarter results for fiscal year 2027. The company reported that its revenue reached a record high, growing by 23% year-over-year, and achieved a record gross margin in the first quarter. Management emphasized that Tilray has built a more diversified global business platform spanning multiple segments, including cannabis, beverages, health, and pharmaceutical distribution, and is committed to transforming this platform into a stronger engine for profit and cash flow growth.

[Core Performance and Strategic Turning Point]

Management pointed out that Tilray is no longer constrained by a single market or single regulatory event. The maturity of its international infrastructure and scaled beverage business allows it to better manage risks and seize opportunities arising from the evolution of global consumer product markets. In the first quarter, the company achieved significant revenue growth while expanding its gross margin, demonstrating the robustness of its financial condition.

[Key Business Developments and Partnerships]

The company has made significant progress in strategic acquisitions, such as successfully integrating BrewDog, which became profitable within the quarter, bringing Tilray brand, global consumer community, and scaled hotel presence. Furthermore, Tilray has entered into a multi-year agreement with Carlsberg Group to introduce European premium beer brands to the US market starting January 1, 2027.

[Drivers of International Business]

International business is one of Tilray's most important growth engines. In the first quarter, revenue in EMEA (Europe, Middle East, and Africa), including medical cannabis, beverages, and pharmaceutical distribution, grew by over 70%. International medical cannabis revenue increased by 21% year-over-year, with sales of flowers and oils growing by 110% and 150% respectively, reflecting the company's advantages in regulatory expertise, scale, and low-cost production.

Tilray's global supply chain design features high vertical integration. For example, about 90% of international cannabis supply comes from facilities in Portugal, which is the cornerstone of the European cannabis business. The company has reduced operating costs by about 40% through optimization in Portugal. Simultaneously, in Germany, the UK, and Italy, Tilray is gaining market share in strictly regulated markets by leveraging its scale and cost control advantages in the medical cannabis sector.

[Future Outlook and Risk Warning]

The company's strategy focuses on continuously creating value through organic growth and targeted acquisitions, utilizing its global platform and brand-building capabilities.[Future Outlook and Risk Warning]

The company's strategy focuses on continuously creating value by leveraging its global platform and brand-building capabilities through organic growth and targeted mergers and acquisitions. Despite the company's continuous expansion of its global footprint, it is consolidating its balance sheet through cost reduction and debt repayment in the face of challenges such as international price compression and geopolitical fuel surcharges.

[Contact Information]

For Tilray Brands' official investor relations information and detailed financial documents, please refer to the company's official website or SEC filings. Before making any investment decisions, please refer to the latest official releases.

[SEO Meta Data]

SEO Title: Tilray Q1 2027 Earnings: Record Revenue Driven by Global Diversification SEO Description: Tilray Brands reported record Q1 2027 revenue growth of 23%. Learn about the company's diversification across cannabis, beverage, wellness, and pharma, including key international expansion and BrewDog integration.

Editor Note: This article is reconstructed based on the key points from the Tilray Brands Q1 2027 earnings conference call, aiming to provide structured, objective corporate information releases for global investors and the media. The content highlights the company's record revenue, business diversification strategy, and substantive progress in international market expansion.

Disclosure Text: The content of this article is organized and reconstructed based on official financial reports and conference call transcripts released by Tilray Brands, aiming to provide a summary of corporate information and does not constitute investment advice. Investors should refer to the official documents.